{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:35:29Z","timestamp":1792096529653,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["509149993"],"award-info":[{"award-number":["509149993"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 374"],"award-info":[{"award-number":["TRR 374"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022854","name":"European Cystic Fibrosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000973","name":"Cystic Fibrosis in Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Foundation for the Advancement of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jcf.2025.12.006","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T20:40:04Z","timestamp":1765226404000},"page":"32-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Elexacaftor\/tezacaftor\/ivacaftor corrects salt-wasting in cystic fibrosis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-2891","authenticated-orcid":false,"given":"Peder","family":"Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8762-4733","authenticated-orcid":false,"given":"Amalie Quist","family":"Rousing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Jensen-Fangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-7220","authenticated-orcid":false,"given":"Sascha","family":"Bandulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Warth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads Vaarby","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2453-216X","authenticated-orcid":false,"given":"Majbritt","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6719-7034","authenticated-orcid":false,"given":"Jens","family":"Leipziger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2025.12.006_bib0001","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2025.12.006_bib0002","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1542\/peds.8.5.648","article-title":"Heat prostration in fibrocystic disease of the pancreas and other conditions","volume":"8","author":"Kessler","year":"1951","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2025.12.006_bib0003","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1542\/peds.12.5.549","article-title":"Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease","volume":"12","author":"Di Sant'Agnese","year":"1953","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2025.12.006_bib0004","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0022-3476(71)80186-5","article-title":"Metabolic alkalosis in cystic fibrosis","volume":"79","author":"Gottlieb","year":"1971","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2025.12.006_bib0005","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1542\/peds.63.4.580","article-title":"Hypoelectrolytemia and metabolic alkalosis in infants with cystic fibrosis","volume":"63","author":"Beckerman","year":"1979","journal-title":"Pediatrics"},{"issue":"Suppl 16","key":"10.1016\/j.jcf.2025.12.006_bib0006","first-page":"38","article-title":"Elevated sweat potassium, hyperaldosteronism and pseudo-Bartter's syndrome: a spectrum of disorders associated with cystic fibrosis","volume":"82","author":"Devlin","year":"1989","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jcf.2025.12.006_bib0007","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1681\/ASN.V82352","article-title":"Cystic fibrosis presenting with hypokalemia and metabolic alkalosis in a previously healthy adolescent","volume":"8","author":"Bates","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcf.2025.12.006_bib0008","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00467-013-2712-4","article-title":"Electrolyte abnormalities in cystic fibrosis: systematic review of the literature","volume":"29","author":"Scurati-Manzoni","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jcf.2025.12.006_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00669-2021","article-title":"Urinary bicarbonate and metabolic alkalosis during exacerbations in cystic fibrosis","volume":"8","author":"Spoletini","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jcf.2025.12.006_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874306401206010059","article-title":"Metabolic alkalosis in adults with stable cystic fibrosis","volume":"6","author":"Al-Ghimlas","year":"2012","journal-title":"Open Respir Med J"},{"key":"10.1016\/j.jcf.2025.12.006_bib0011","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1681\/ASN.2020010053","article-title":"Impaired renal HCO3 (-) excretion in cystic fibrosis","volume":"31","author":"Berg","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcf.2025.12.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13591","article-title":"Impaired renal HCO3 (-) secretion in CFTR deficient mice causes metabolic alkalosis during chronic base-loading","volume":"231","author":"Berg","year":"2021","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.jcf.2025.12.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116836119","article-title":"Alkalosis-induced hypoventilation in cystic fibrosis: the importance of efficient renal adaptation","volume":"119","author":"Berg","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2025.12.006_bib0014","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.7326\/M22-1741","article-title":"Challenged urine bicarbonate excretion as a measure of cystic fibrosis transmembrane conductance regulator function in Cystic fibrosis","volume":"175","author":"Berg","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcf.2025.12.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14233","article-title":"The challenged urine bicarbonate excretion test in cystic fibrosis: a comprehensive analysis of urine acid\/base parameters","volume":"240","author":"Rousing","year":"2024","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.jcf.2025.12.006_bib0016","article-title":"CFTR knock-out mice exhibit impaired renal compensation to dietary NaCl depletion","author":"Berg","year":"2025","journal-title":"Inrevision"},{"key":"10.1016\/j.jcf.2025.12.006_bib0017","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1203\/00006450-197111000-00007","article-title":"The Renin-Angiotensin-aldosterone system in patients with cystic fibrosis of the pancreas","volume":"5","author":"Simopoulos","year":"1971","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcf.2025.12.006_bib0018","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-82-6-806","article-title":"Low blood pressure in young adults with cystic fibrosis: an effect of chronic salt loss in sweat?","volume":"82","author":"Lieberman","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcf.2025.12.006_bib0019","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000145901.81989.46","article-title":"Blood pressure and the cystic fibrosis gene: evidence for lower pressure rises with age in female carriers","volume":"44","author":"Super","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jcf.2025.12.006_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01253-2023","article-title":"Cystic fibrosis and the cardiovascular system: the unexpected heartache","volume":"62","author":"Hebestreit","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2025.12.006_bib0021","doi-asserted-by":"crossref","first-page":"sfae256","DOI":"10.1093\/ckj\/sfae256","article-title":"Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis","volume":"17","author":"Gabai","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jcf.2025.12.006_bib0022","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2025.12.006_bib0023","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.202110-2249OC","article-title":"Effects of Elexacaftor\/Tezacaftor\/Ivacaftor therapy on CFTR function in patients with cystic fibrosis and one or two F508del alleles","volume":"205","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2025.12.006_bib0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcf.2025.12.006_bib0026","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jand.2020.05.011","article-title":"Sodium status and replacement in children and adults living with Cystic Fibrosis: a narrative review","volume":"120","author":"Declercq","year":"2020","journal-title":"J Acad Nutr Diet"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325025378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325025378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:15:09Z","timestamp":1778620509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325025378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1569199325025378"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.12.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elexacaftor\/tezacaftor\/ivacaftor corrects salt-wasting in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}